Skip to main content
Clinical Trials/NL-OMON27835
NL-OMON27835
Not Yet Recruiting
N/A

A prospective cohort study to investigate the use of avb3-integrin scintigraphic imaging with 99mTc-NC100692 as a surrogate endpoint for therapeutic interventions in patients with myocardial infarction.

Maastricht University Medical Center0 sites123 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Maastricht University Medical Center
Enrollment
123
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. The subject has had no previous MI (a previous MI/scar could potentially result in tracer uptake and therefore interfere with the imaging outcome), presents with acute MI and has undergone coronary angiography during which percutaneous coronary intervention (PCI) or no intervention may be performed. The documentation of coronary anatomy and disease will be linked to the imaging outcome;
  • 2\. The subject is \>18 years of age at study entry. Maximum age is 80 years, provided patients are in good condition;

Exclusion Criteria

  • 1\. The subject was previously entered into this study or has participated in any other IMP study within 30 days of study entry, since this could interfere with the medications tested;
  • 2\. The subject is scheduled to receive another IMP from time of entry into this study until completion of the follow\-up period after the second injection proposed for this study, since this could interfere with the medications and endpoints tested;

Outcomes

Primary Outcomes

Not specified

Similar Trials